PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsalcohol withdrawal delirium
MeSH D000430 - alcohol withdrawal delirium
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D013375:Substance withdrawal syndrome
$
Success rate
D019973:Alcohol-related disorders
$
Success rate
D020268:Nervous system alcohol-induced disorders
$
Success rate
D000430: 
Alcohol withdrawal delirium
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaChlordiazepoxide Chlordiazepoxide  1982-01-01   
Chlordiazepoxide, Clidinium Chlordiazepoxide Clidinium  2021-11-02   
Diazepam Diazepam  1985-11-01   
MylanChlordiazepoxide Chlordiazepoxide  1982-01-01   
Amitriptyline, Chlordiazepoxide Chlordiazepoxide Amitriptyline  1986-12-10   
Diazepam Diazepam  1985-09-04   
RocheChlordiazepoxide, Estrogens, esterified Menrium  1982-01-01   
Diazepam Valium  1982-01-01   
Diazepam Valrelease  1982-01-01   
Bausch Health CompaniesDiazepam Diastat Acudial  1997-07-29   
Chlordiazepoxide, Clidinium Librax  1982-01-01   
Chlordiazepoxide Librelease  1983-09-12   
Chlordiazepoxide Libritabs  1982-01-01   
Chlordiazepoxide Librium  1982-01-01   
PfizerChlordiazepoxide Chlordiazepoxide  1982-01-01   
Aurobindo PharmaChlordiazepoxide, Clidinium Chlordiazepoxide Clidinium  2023-09-14   
Diazepam Diazepam  2023-12-14   
Barr PharmaceuticalsChlordiazepoxide Chlordiazepoxide  1982-01-01   
Diazepam Diazepam  1985-11-01   
Dr Reddys LaboratoriesChlordiazepoxide, Clidinium Chlordiazepoxide Clidinium  2021-05-10   
Diazepam Diazepam  1987-02-03   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
67%
2/3
Phase 2
50%
3/6
Phase 3
100%
7/7
Approved: 6Overall Success rate: 33%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use